Candel Therapeutics, Inc.
CADL
Revenue
32.00k
▲1.00k▲3.23%
3 Months ChangeAssets
26.49M
▼-4.73M▼-15.16%
3 Months ChangeLiabilities
36.46M
▲11.22M▲44.45%
3 Months ChangeFree Cash Flow
-8.45M
▲2.51M▲22.93%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0000950170-24-117578
2024-08-13
Form 10-Q
ID: 0000950170-24-095784
2024-08-13
Form 8-K
ID: 0000950170-24-095775
2024-06-28
Form 8-K
ID: 0000950170-24-078795
2024-05-30
Form 8-K
ID: 0000950170-24-066608
2024-05-23
Form 8-K
ID: 0000950170-24-064022
2024-05-14
Form 10-Q
ID: 0000950170-24-059118
2024-05-14
Form 8-K
ID: 0000950170-24-059109
2024-04-25
Form 8-K
ID: 0000950170-24-047941
2024-04-11
Form 8-K
ID: 0000950170-24-043532